Log in or Sign up for Free to view tailored content for your specialty!
Gastrointestinal Infections News
VIDEO: Current treatment options for C. difficile infection
In these videos, Jessica R. Allegretti, MD, MPH, medical director of the Crohn's and Colitis Center at the Brigham and Women's Hospital discusses the latest treatments, preventative options, and unmet needs for patients with Clostridioides difficile infection.
VIDEO: Questions patients may have about C. difficile treatment
In these videos, Jessica R. Allegretti, MD, MPH, medical director of the Crohn's and Colitis Center at the Brigham and Women's Hospital discusses the latest treatments, preventative options, and unmet needs for patients with Clostridioides difficile infection.
Log in or Sign up for Free to view tailored content for your specialty!
VIDEO: Importance of early diagnosis, treatment of Clostridioides difficile infection
In these videos, Jessica R. Allegretti, MD, MPH, medical director of the Crohn's and Colitis Center at the Brigham and Women's Hospital discusses the latest treatments, preventative options, and unmet needs for patients with Clostridioides difficile infection.
Multidrug-resistant bacteria prevalent in supermarket meat, study finds
Researchers in Spain reported that nearly half of supermarket meat samples tested in a study contained multidrug-resistant or potentially pathogenic Escherichia coli.
FDA approves Vowst as first oral microbiota biotherapeutic for recurrent C. difficile
The FDA has approved Vowst, the first orally administered fecal microbiota product indicated for the prevention of recurrent Clostridioides difficile infection in adults following antibacterial treatment.
Novel alternative to fecal microbiota therapy prevents recurrent CDI in study
A novel oral microbiome-directed therapy called VE303 successfully prevented recurrent Clostridioides difficile infection in adults at high risk for recurrence, researchers found.
Fecal transplants for babies born by cesarean section may contain harmful pathogens
More than 40% of healthy mothers recruited for a study testing fecal transplantation for babies born by cesarean section tested positive for potentially harmful pathogens, Finnish researchers reported.
FDA clears Meridian Bioscience’s Shiga Toxin test, expanding GI testing platform
Meridian Bioscience has announced FDA 510(k) clearance of its Curian Shiga Toxin assay intended for detection and differentiation of Shiga toxin 1 and 2 within a single device, according to a company release.
Hooked on ID with Rachael A. Lee, MD, MSPH
As the product of two hard-working academic physicians, I have never been without incredible examples of leaders in the field of medicine.
Adenovirus re-emerges as likely culprit in 2022 outbreak of acute hepatitis in children
A 2022 outbreak of unexplained acute severe hepatitis in children has been linked to a strain of adeno-associated virus 2, supporting the theory that disease pathogenesis results from viral coinfection, according to data reported in Nature.
-
Headline News
Rise in alcohol use during pandemic endures as 'an alarming public health issue'
November 14, 20242 min read -
Headline News
AI identified patient messages sent by proxies, but also broke confidentiality
November 14, 20242 min read -
Headline News
Diabetes inequities persist worldwide, especially for low-, middle-income countries
November 14, 20243 min read
-
Headline News
Rise in alcohol use during pandemic endures as 'an alarming public health issue'
November 14, 20242 min read -
Headline News
AI identified patient messages sent by proxies, but also broke confidentiality
November 14, 20242 min read -
Headline News
Diabetes inequities persist worldwide, especially for low-, middle-income countries
November 14, 20243 min read